Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J‐EDIT)

Diabetes/Metabolism Research and Reviews - Tập 22 Số 5 - Trang 376-384 - 2006
Taichi Akisaki1, Takashi Sakurai1, Toshihiro Takata1, Hiroyuki Umegaki2, Atsushi Araki3, Shinsuke Mizuno4, Shiro Tanaka4, Yasuo Ohashi4, Akihisa Iguchi2, Koichi Yokono1, Hideki Ito5
1Department of Internal and Geriatric Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
2Department of Geriatrics, Nagoya University Graduate School of Medicine, Aichi, Japan.
3Department of Endocrinology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
4Department of Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences and Nursing, Tokyo University, Tokyo, Japan
5Tokyo Metropolitan Health and Treatment Corporation, Tama‐Hokubu Medical Center, Tokyo, Japan

Tóm tắt

AbstractBackgroundType 2 diabetes is associated with cognitive dysfunction and increases the risk of dementia in the elderly. The aim of this study was to explore, by means of magnetic resonance (MR) imaging, possible relationships among clinical profiles of diabetes, cognitive function, white matter hyperintensities (WMHs) and subcortical brain atrophy.MethodsData were obtained from 95 nondemented type 2 diabetic participants aged 65 years or over, enrolled in an intervention trial for Japanese elderly diabetic patients. Cognitive function was measured with neuropsychiatric tests, including mini‐mental state examination (MMSE), verbal memory, digit symbol substitution and Stroop tests. Hyperintensity was classified into periventricular, deep white matter, thalamic and basal ganglia. Four ventricle‐to‐brain ratios were used to measure subcortical atrophy. To identify clinical features of diabetes, indices of glycemic control, lipid metabolism, blood pressure and complications were examined. Canonical correlation analysis and regression analysis were used to assess correlation.ResultsScores for digit symbol substitution and MMSE negatively correlated with WMHs in the parietal lobe and hyperintensities in the thalamus, respectively. Lower scores for memory and digit symbol substitution showed positive association with enlarged subcortical atrophy adjacent to lateral ventricles. There was no association between clinical pictures of diabetic patients with cognitive dysfunction and of those with morphological changes in the brain.ConclusionsImpaired cognitive domains of the speed of mental processes and memory were associated with WMHs and subcortical atrophy. Degenerative changes in the cerebral small vessels may constitute predictive factors for the rate of cognitive dysfunction in elderly diabetic patients. Copyright © 2006 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1002/dmrr.296

10.1185/030079904X6291

10.1001/archinte.1922.00110120086003

10.2337/diacare.20.3.438

10.1212/WNL.53.9.1937

10.1093/aje/154.7.635

10.2337/diabetes.51.4.1256

10.1159/000064928

10.1001/archneur.61.5.661

10.1016/S0166-2236(00)01656-8

10.1016/j.ejphar.2004.02.048

10.1016/j.neuron.2004.09.006

10.1002/gps.1283

The Expert Committee On the Diagnosis and Classification of Diabetes Mellitus, 2003, Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 26, 5, 10.2337/diacare.26.2007.S5

American Psychiatric Association, 1994, Diagnostic and Statistical Manual of Mental Disorders

Amiel SA, 2005, Iatrogenic Hypoglycemia, 671

10.1111/j.1468-1331.2004.00972.x

10.1002/1531-8249(200002)47:2<145::AID-ANA3>3.0.CO;2-P

Erkinjuntti T, 2000, Research criteria for subcortical vascular dementia in clinical trials, J Neural Transm Suppl, 59, 23

10.1001/archneurpsyc.1942.02290060069004

10.1007/BF00496984

Sawai F, 1987, Computed tomographical diagnosis of brain atrophy by aging, J Nara Med Assoc, 38, 974

10.1046/j.1444-1586.2001.00013.x

10.1037/h0054651

Wechsler D, 1981, Manual for the Wechsler Adult Intelligence Scale‐Revised

Mohs RC, 1983, The Alzheimer's disease assessment scale; an instrument for assessing treatment efficacy, Psychopharmacol Bull, 19, 448

Ueda M, 1996, Memory disorders in the elderly stage of dementia of the Alzheimer type: preliminary findings, Jpn J Neuropsychology, 12, 178

10.1016/0022-3956(75)90026-6

Johnson RA, 2002, Applied Multivariate Statistical Analysis

Razavi AR, 2005, Exploring cancer register data to find risk factors for recurrence of breast cancer—application of canonical correlation analysis, BMC Med Inform Decis Mak, 22, 5

10.1207/s15327752jpa8401_09

10.1111/j.1749-6632.2002.tb04849.x

10.1093/brain/awf077

10.1001/archneur.1993.00540080029009

10.1212/WNL.43.12.2490

10.1161/01.STR.26.7.1171

10.1037/0894-4105.14.2.224

10.1002/ana.10294

10.1212/WNL.50.6.1535

10.1161/01.STR.0000087786.38997.9E

10.1016/0165-0173(90)90004-8

Salmon E, 1994, Differential diagnosis of Alzheimer's disease with PET, J Nucl Med, 35, 391

10.1212/WNL.43.9.1683

10.1111/j.1749-6632.2002.tb04845.x

10.1016/S0197-4580(01)00319-0

10.1161/01.STR.27.8.1274

10.1037/0735-7044.117.6.1169

10.2214/ajr.181.2.1810571

10.1046/j.1464-5491.2001.00577.x

10.1016/S1056-8727(03)00078-3

10.2337/diacare.28.1.71

10.1007/s00125-003-1235-0

10.1007/BF00399961

10.1016/S1056-8727(01)00143-X

10.1074/jbc.272.28.17810

10.1016/j.freeradbiomed.2004.02.006

10.1038/382685a0

10.1038/380168a0

10.1080/152165400410281

10.1161/01.STR.26.4.593

10.1016/0168-8227(96)01196-5

10.1136/jnnp.74.10.1371

10.1080/03610730590882837

10.1212/01.WNL.0000149641.55751.2E

10.1016/S0140-6736(98)03086-4

10.1016/S0140-6736(00)03155-X

Kristine Y, 2002, Serum lipoprotein levels, stain use, and cognitive function in older women, Arch Neurol, 59, 378, 10.1001/archneur.59.3.378

Shepherd J, 2004, A prospective study of pravastatin in the elderly at risk: New hope for older persons, Am J Geriatr Cardiol, 13, 17